Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedNot reportedPublished in a peer-reviewed journal

Associations of Restless Legs Syndrome with Various Neurological Disorders

An analysis of 119 unique studies found significant associations between restless legs syndrome (RLS) and several neurological conditions, including Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis, among others.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Not established from this source
Mechanism
Not reported
Evidence strength
Not graded
Outcome
Not reported

Why it matters

These findings suggest that RLS may be linked to a variety of neurological disorders, which could influence further research into understanding these associations and their underlying mechanisms.

What this does not prove

The findings are based on observational studies, which can indicate associations but do not confirm causation. Additionally, the studies included are heterogeneous.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Not reported
Participants / samples
119 · unique studies
Randomised
Not reported
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-10-17
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
Not reported
Size of effect
Not reported
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (6)
sample size119
sample size basisunique studies
publication date2026-10-17
findingsIn our exploratory synthesis of 119 unique studies, RLS was significantly associated with Parkinson's disease (case-control OR 3.22, 95% CI 2.35-4.41; cohort RR 1.74, 95% CI 1.02-2.95), multiple sclerosis (OR 4.04, 95% CI 3.26-5.00), neuromyelitis optica spectrum disorder (OR 2.91, 95% CI 1.45-5.84), migraine or headache disorders (forward OR 2.72, 95% CI 2.19-3.38; reverse adjusted OR 1.53, 95% CI 1.36-1.73), peripheral neuropathy (OR 3.82, 95% CI 2.49-5.83), epilepsy (OR 2.11, 95% CI 1.58-2.82), and amyotrophic lateral sclerosis (OR 7.69, 95% CI 2.74-21.59).
limitationsHowever, the current evidence remains observational and heterogeneous.
peer reviewedPublication types: Journal Article; Review

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.